Castle Institutional Review Board (Castle IRB), a subsidiary of Sabai Global

Castle Institutional Review Board (Castle IRB), a subsidiary of Sabai Global, is dedicated to protecting the rights and welfare of human participants in gene and cell therapy clinical trials within the health care industry. Established in 2019, the company's slogan "Independent IRB. Gene & cell therapy. Rare disease. Expert Ethics Board. Concierge support/consulting. AAHRPP accredited" reflects its focus on providing efficient and compliant IRB review of research, particularly in gene and cell therapy. Castle IRB's mission is aimed at advancing safe, ethical, and compliant gene and cell therapy clinical trials, essentially contributing to the growth and development of advanced therapies. Their approach leverages a portfolio of expertise, positioning them as a leading IRB partner in this evolving field. Despite the absence of specific details on their headquarter location and last investment, Castle IRB's commitment to ethical clinical trials in gene and cell therapy presents an opportunity for potential investors seeking involvement in the health care sector.